Recently Dr Carmen Martínez Fernández was incorporated as a postdoc into the Dr Griñan-Ferré group on Neuroepigenetics and Drug Discovery. Dr Martínez-Fernández will be in charge of Behavioural phenotypes evaluation (locomotion, mechano- and chemosensation) and Gene editing by CRISPR/Cas by using as experimental model C. elegans. She will participate in several projects lead By Dr Griñán-Ferré related with drug development.